GLG News Analyses of the following article:

Novartis to invest US$ 1 bn to build largest pharma R&D institute in China

Published at: www.pharmabiz.com

Novartis, Sleeping Giant Wakes-Up in China

November 6, 2009

Novartis to grow its China presence, late.Novartis has a slow response to market opportunities.GlaxoSmithKline and other big pharma players are perhaps too large to compete in the world's changing markets.

Request a News Analysis

Subscribe to Updates

By RSS

Work for one of the world's leading organizations? Get started now.

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading: mutual funds
15 of the leading 20: global banks
7 of the leading 10: global private equity firms
5 of the leading 10: AmLaw firms
Fortune 500^® Companies: in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software

Novartis to invest US$ 1 bn to build largest pharma R&D institute in China

Work for one of the world's leading organizations? Get started now.

Get Intelligently Connectedwith the world's leading experts

GLG's 850+ Clients Include:

Get Intelligently Connected
with the world's leading experts